-transparent.png){kind=logo}
The effects of tolbutamide infusion (1 gm. over forty minutes) on plasma pancreatic glucagon-like immunoreactivity (PGLI), serum insulin, and blood glucose were studied in six patients with chronic pancreatitis and six matched controls.asal PGLI levels were significantly higher in the patients, despite higher fasting glucose concentrations. Tolbutamide infusion had no significant effect on mean PGLI levels in controls but was associated with significant elevation in pancreatitis patients, despite higher circulating glucose levels in the latter. The data suggest that chronic calcific pancreatitis patients hypersecrete immunoreactive glucagon, possibly from a nonpancreatic source and that this immunocreactive material may be stimulated by sulfonylureas.
W J Kalk, and
A I Vinik, and
M Paul, and
P Leller, and
W P Jackson
April 1977,
The Alabama journal of medical sciences,
W J Kalk, and
A I Vinik, and
M Paul, and
P Leller, and
W P Jackson
November 1976,
Metabolism: clinical and experimental,
W J Kalk, and
A I Vinik, and
M Paul, and
P Leller, and
W P Jackson
May 1977,
The Journal of clinical endocrinology and metabolism,
W J Kalk, and
A I Vinik, and
M Paul, and
P Leller, and
W P Jackson
June 1970,
Diabetes,
W J Kalk, and
A I Vinik, and
M Paul, and
P Leller, and
W P Jackson
June 1975,
West African journal of pharmacology and drug research,
W J Kalk, and
A I Vinik, and
M Paul, and
P Leller, and
W P Jackson
December 1977,
The Journal of clinical endocrinology and metabolism,
W J Kalk, and
A I Vinik, and
M Paul, and
P Leller, and
W P Jackson
January 1979,
Hormone research,
W J Kalk, and
A I Vinik, and
M Paul, and
P Leller, and
W P Jackson
June 1972,
Israel journal of medical sciences,
W J Kalk, and
A I Vinik, and
M Paul, and
P Leller, and
W P Jackson
June 1971,
Acta endocrinologica,
W J Kalk, and
A I Vinik, and
M Paul, and
P Leller, and
W P Jackson
October 1963,
The American journal of the medical sciences,
